바이오인포매틱스 서비스 시장 규모, 점유율 및 동향 분석 보고서 : 유형별, 용도별, 부문별, 지역별 및 부문별 예측(2026-2033년)

Bioinformatics Services Market Summary

The global bioinformatics services market size was estimated at USD 3.6 billion in 2025 and is projected to reach USD 11.2 billion by 2033, growing at a CAGR of 15.4% from 2026 to 2033. Market growth is being driven by the increasing adoption of next-generation sequencing (NGS), rising investments in genomics and proteomics research, and the growing demand for data analysis solutions in drug discovery and precision medicine. The surge in biologics and personalized therapeutics development, along with advancements in artificial intelligence and cloud-based bioinformatics platforms, is further accelerating market expansion.

Global Bioinformatics Services Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global bioinformatics services market report based on the type, application, sector, and region:

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• NGS
  • Targeted Sequencing Analysis
  • Transcriptome Analysis
  • Whole Genome
  • Chip Seq Analysis
  • De novo Assembly
  • Methyl Seq Analysis
• Chemoinformatics
  • Sequence Analysis Platforms
  • Molecular Modeling
  • Docking
  • Clinical trial data management
  • Others
• Microarray data analysis
• Biological data curation
• Scientific software testing
• Other services
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Genomics
• Transcriptomics
• Proteomics
• Metabolomics
• Drug Discovery
• Others
• Sector Outlook (Revenue, USD Million, 2021 - 2033)
• Medical
• Animal
• Agricultural
• Academics
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Type
  • 1.2.2. Application
  • 1.2.3. Sector
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Biohacking Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Market Restraint Analysis:
      • 3.2.1.1.1. Increasing adoption of next-generation sequencing (NGS) technologies
      • 3.2.1.1.2. Growing demand for precision medicine & genomic research
      • 3.2.1.1.3. Rising investments & government initiatives
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost associated with advanced bioinformatics tools and data analysis platforms
    • 3.2.2.2. High data security concerns
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenges Analysis
• 3.3. Case Study Insights
• 3.4. Industry Analysis Tools
  • 3.4.1. Porter's Five Forces Analysis
  • 3.4.2. PESTEL Analysis

Chapter 4. Bioinformatics Services Market: Type Estimates & Trend Analysis

• 4.1. Type Segment Dashboard
• 4.2. Global Bioinformatics Services Market Type Movement Analysis
• 4.3. Global Bioinformatics Services Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 4.4. NGS
  • 4.4.1. NGS Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Targeted Sequencing Analysis
    • 4.4.2.1. Targeted Sequencing Analysis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Transcriptome Analysis
    • 4.4.3.1. Transcriptome Analysis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. Whole Genome
    • 4.4.4.1. Whole Genome Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.5. Chip Seq Analysis
    • 4.4.5.1. Chip Seq Analysis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.6. De novo Assembly
    • 4.4.6.1. De novo Assembly Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.7. Methyl Seq Analysis
    • 4.4.7.1. Methyl Seq Analysis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Chemoinformatics
  • 4.5.1. Chemoinformatics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. Sequence Analysis Platforms
    • 4.5.2.1. Sequence Analysis Platforms Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. Molecular Modeling
    • 4.5.3.1. Molecular Modeling Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.4. Docking
    • 4.5.4.1. Docking Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.5. Clinical trial data management
    • 4.5.5.1. Clinical Trial Data Management Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.6. Others
    • 4.5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Microarray Data Analysis
  • 4.6.1. Microarray Data Analysis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Biological Data Curation
  • 4.7.1. Biological Data Curation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Scientific Software Testing
  • 4.8.1. Scientific Software Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Other Services
  • 4.9.1. Other Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Bioinformatics Services Market: Application Estimates & Trend Analysis

• 5.1. Application Segment Dashboard
• 5.2. Global Bioinformatics Services Market Application Movement Analysis
• 5.3. Global Bioinformatics Services Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Genomics
  • 5.4.1. Genomics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Transcriptomics
  • 5.5.1. Transcriptomics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Proteomics
  • 5.6.1. Proteomics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Metabolomics
  • 5.7.1. Metabolomics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Drug Discovery
  • 5.8.1. Drug Discovery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. Others
  • 5.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Bioinformatics Services Market: Sector Estimates & Trend Analysis

• 6.1. Sector Segment Dashboard
• 6.2. Global Bioinformatics Services Market Sector Movement Analysis
• 6.3. Global Bioinformatics Services Market Size & Trend Analysis, by Sector, 2021 to 2033 (USD Million)
• 6.4. Medical
  • 6.4.1. Medical Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Animal
  • 6.5.1. Animal Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Agricultural
  • 6.6.1. Agricultural Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Academics
  • 6.7.1. Academics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Bioinformatics Services Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2025 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 7.4. North America
  • 7.4.1. North America Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. U.S. Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Canada Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. Mexico Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. UK Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Germany Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. France Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. Italy Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Spain Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. Denmark
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Denmark Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Sweden Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.9. Norway
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Norway Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Japan Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. China Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. India Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.5. Australia
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Australia Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.6. Thailand
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Thailand Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.7. South Korea
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. South Korea Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Brazil Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Argentina Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. South Africa Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Saudi Arabia Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. UAE Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Kuwait Bioinformatics Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Categorization
• 8.2. Company Market Position Analysis, 2024
• 8.3. Participant's Overview
  • 8.3.1. Agilent Technologies, Inc.
    • 8.3.1.1. Participant's Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Product Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. BGI Group
    • 8.3.2.1. Participant's Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Product Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. Dotmatics
    • 8.3.3.1. Participant's Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Product Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. Labvantage - Biomax GmbH
    • 8.3.4.1. Participant's Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Product Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. CD Genomics
    • 8.3.5.1. Participant's Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Product Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Creative Biolabs
    • 8.3.6.1. Participant's Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Product Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. DNAnexus, Inc.
    • 8.3.7.1. Participant's Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Product Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. DNASTAR
    • 8.3.8.1. Participant's Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Product Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Fios Genomics
    • 8.3.9.1. Participant's Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Product Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. Illumina, Inc.
    • 8.3.10.1. Participant's Overview
    • 8.3.10.2. Financial Performance
    • 8.3.10.3. Product Benchmarking
    • 8.3.10.4. Strategic Initiatives
  • 8.3.11. PerkinElmer Inc.
    • 8.3.11.1. Participant's Overview
    • 8.3.11.2. Financial Performance
    • 8.3.11.3. Product Benchmarking
    • 8.3.11.4. Strategic Initiatives
  • 8.3.12. QIAGEN
    • 8.3.12.1. Participant's Overview
    • 8.3.12.2. Financial Performance
    • 8.3.12.3. Product Benchmarking
    • 8.3.12.4. Strategic Initiatives
  • 8.3.13. Thermo Fisher Scientific Inc.
    • 8.3.13.1. Participant's Overview
    • 8.3.13.2. Financial Performance
    • 8.3.13.3. Product Benchmarking
    • 8.3.13.4. Strategic Initiatives